References list
1. Fehr T, Cippà PE, Mueller NJ. Cytomegalovirus post kidney transplantation: prophylaxis versus pre-emptive therapy? Transplant Int. 2015;28(12):1351-1356. doi:10.1111/tri.12640.
2. Santos CA. Cytomegalovirus and Other β-Herpesviruses. Semin Nephrol. 2016;36(5):351–361.
3. Tufano A, Contaldi P, Coppola A, Nardo A, Franco N, Cerbone AM, Minno GD. Cytomegalovirus-Associated Splanchnic Vein Thrombosis in Immunocompetent Patients: Two Case Reports and Literature Review. Semin Thromb Hemost. 2018;44(3):298–303.
4. Hotta K, Fukasawa Y, Wada Y, Fukuzawa N, Seki T, Harada H. Cytomegalovirus peritonitis after kidney transplantation diagnosed through histopathological examination. Transpl Infect Dis. 2017;19(4):e12708. doi:10.1111/tid.12708.
5. Nuansri S, Kantachuvesiri S, Watcharananan SP, Thongprayoon C, Cheungpasitporn W, Bruminhent J. Clinical Characteristics of Late-Onset Cytomegalovirus Infection After Kidney Transplantation. Transplant Proc. 2021;53(7):2267-2271.
6. Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TM, Campos SV, Ramos JF, Latif AZ, Litvinov N, Maluf NZ, Caiaffa Filho HH, Pannuti CS, Lopes MH, Santos VA, Linardi CdaC, Yasuda MA, Marques HH. Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo, Brazil). 2015;70(7):515–523.
7. Ceccarelli M, Venanzi Rullo E, Nunnari G. Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals: A systematic review. Eur J Clin Microbiol Infect Dis. 2018;37(3):381–390.
8. Wang L, Hsu Y, Sharma N. Thrombosis associated with Cytomegalovirus (CMV) in a kidney transplant recipient. Cureus. 2021;13(9):e17745. doi:10.7759/cureus.17745.
9. Pleško J, Kovač D, Arsov Z, Lindič J, Škoberne A, Ferluga D, Kojc N. Glomerular and tubulointerstitial foscarnet nephropathy of kidney allograft with emphasis on ultrastructural findings: A case report. Clin Nephrol. 2021;96(1):127–132. doi:10.5414/CNP96S23.
10. Harrison C, Scull MA. Antiviral drug discovery: A personal retrospective. Antiviral Res. 2019;167:104-112. doi:10.1016/j.antiviral.2019.06.004.
11. Liu Y, Liang Y, Zhang J, Han R. The association between social support and anxiety/depression among renal transplant recipients during the COVID-19 outbreak: A cross-sectional online survey. Transpl Infect Dis. 2020;22(6):e13441. doi:10.1111/tid.13441.
12. Rahman M, Griffin RL. Secondary hyperparathyroidism: Pathophysiology, diagnosis, and treatment. Nephrology. 2017;22(3):88-98. doi:10.1111/nep.12767.
13. de Souza JA, Gonçalves R, Zanetta DMT. Nursing workload in a renal transplant unit: A cross-sectional study. J Bras Nefrol. 2019;41(1):76-83. doi:10.1590/2175-8239-jbn-2018-0012.
14. Johnston O, Rose CL. The ethics of renal transplantation. Am J Kidney Dis. 2020;75(6):936-943. doi:10.1053/j.ajkd.2019.10.010.
15. Al-Malki T, Alharthi S. Renal transplantation in children: An updated review. Pediatr Transplant. 2020;24(6):e13538. doi:10.1111/petr.13538.
16. Mehraban D, Seraj M. Treatment adherence and its affecting factors in kidney transplant recipients in Iran. Int Urol Nephrol. 2012;44(5):1297-1303. doi:10.1007/s11255-012-0293-y.
17. Lora AM, Khine J, Khosrodad N, Yeldandi V. Unusual manifestations of acute cytomegalovirus infection in solid organ transplant hosts: A report of two cases. Case Rep Transplant. 2017;2017:4916973. doi:10.1155/2017/4916973.
18. Falagas ME, Vouloumanou EK. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacteria: Systematic evaluation of the available evidence. Infection. 2014;42(2):163-173. doi:10.1007/s15010-014-0714-1.
19. Musiał K, Zwolińska D, Polak-Jonkisz D. Current status of pediatric pancreas transplantation. Ann Transplant. 2015;20:444-450. doi:10.12659/AOT.892076.
20. Ayvazoglu Soy EH, Moray G, Sönmez MG, Haberal M. Comparison of the efficacy and safety of basiliximab versus thymoglobulin induction therapy in live donor renal transplant recipients: A single-center experience. Transplant Proc. 2017;49(3):457-460. doi:10.1016/j.transproceed.2017.02.046.
21. Moray G, Ayvazoglu Soy EH, Sönmez MG, Haberal M. Comparison of the efficacy and safety of basiliximab and thymoglobulin induction therapy in deceased donor renal transplant recipients. Transplant Proc. 2017;49(8):1773-1779. doi:10.1016/j.transproceed.2017.09.058.
22. de Freitas JS, Kummer AM, Salomão JB, Borba HHL. Clinical and histological aspects of chronic allograft nephropathy in kidney transplant recipients. J Bras Nefrol. 2020;42(3):263-270. doi:10.1590/2175-8239-JBN-2020-0254.
23. Baid-Agrawal S, Halloran PF. Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2015;75(4):437-450. doi:10.1007/s40265-015-0365-5.
24. Naciri Bennani H, Wissing KM, Abramowicz D. Long-term medical complications in renal transplant recipients: Experience from a single center. Transplant Proc. 2014;46(6):1895-1901. doi:10.1016/j.transproceed.2014.03.081.
25. Gomes IB, de Lourdes Aguiar Oliveira M, de Castro MCA. Infection prevention and control in solid organ transplantation. Transpl Infect Dis. 2014;16(3):353-367. doi:10.1111/tid.12105.
26. Hailat AQ. Attitudes toward organ donation among university students in Jordan. J Public Health. 2017;25(4):387-392. doi:10.1007/s10389-017-0771-7.
27. Kim YK, Kim JK, Park KM, Chung WH. Analysis of the efficacy and safety of a calcineurin inhibitor-free immunosuppressive protocol in kidney transplant recipients with hepatitis C virus infection. Transplant Proc. 2016;48(5):1585-1590. doi:10.1016/j.transproceed.2016.02.036.
28. Akoh JA. Perioperative management of the obese surgical patient. J Perioper Pract. 2016;26(5):92-96. doi:10.1177/1203475416650643.
29. Borg MA, Zarb P, Scicluna EA, Rasslan O, Gür D, Ben Redjeb S. The impact of enhanced infection control at a tertiary care hospital - a decade of experience reducing healthcare associated infections. BMC Infect Dis. 2014;14:259. doi:10.1186/1471-2334-14-259.
30. Iwai T, Uchida J, Kosoku A, Kabei K, Nishide S, Naganuma T, Maeda K, Yoshikawa Y, Kumada N, Takemoto Y, Nakatani T. Splenectomy for ABO-Incompatible Kidney Transplantation and Very Late-Onset Cytomegalovirus Disease. Urol Int. 2020;104(7-8):651–656.
31. Bhasin H, Patel N, Arachchi A. Pyomyositis in a diabetic patient: A rare case report. BMJ Case Rep. 2020;13(1):e231662. doi:10.1136/bcr-2019-231662.
32. Katsube O, Kitamura T, Maruyama K. A case of IgG4-related disease with multiple lung nodules. Intern Med. 2017;56(23):3173-3176. doi:10.2169/internalmedicine.8815-17.
33. Sforza D, Iaria G, Tariciotti L, Manuelli M, Anselmo A, Ciano P, Tisone G. Deep vein thrombosis as debut of cytomegalovirus infection associated with type II cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report. Transplant Proc. 2013;45(7):2782-2784. doi:10.1016/j.transproceed.2013.07.055.